Both share the GLP-1 class side-effect profile, led by gastrointestinal symptoms: nausea, vomiting, diarrhea, and constipation, worst during dose increases
From there, lower tirzepatide doses (2.5 mg) map to lower semaglutide doses, and higher tirzepatide doses (10 to 15 mg) exceed what semaglutide can match at any single dose
The role of nutrition in chronic disease
Five PK studies all reported that children under 12 years of age metabolise paracetamol predominately by sulphation compared with adults ( n = 114 children in total) and that the adult pattern of metabolism is present beyond the age of 12 [44,45,46,47,48]
Comparison with benchmark shown
If your body is still: Inflamed Nutrient deficient Dependent on processed foods Youre not building long-term healthyoure just suppressing appetite